Transactions

Minute Molecular Diagnostics Merges with Nuclein

NEW YORK – Rapid point-of-care qPCR systems developers Nuclein and Minute Molecular Diagnostics announced on Thursday that they have merged. The combined firm, called Nuclein, plans to advance commercialization of a rapid, low-cost qPCR system this summer. Financial terms of the merger were not disclosed. The Nuclein management team will be responsible for daily operations moving forward, while Minute Molecular's former leadership team will continue to support the company. Wally Narajowski, Minute's former chief operating officer, is joining Nuclein's board of directors. The merger …

Sale of Dascena Labs to CirrusDx

CirrusDx Acquires Dascena's Texas Laboratory Business, Expanding Infectious Disease Portfolio ROCKVILLE, Md., Aug. 3, 2022 /PRNewswire/ -- Cirrus Dx, Inc. ("CirrusDx"), an infectious disease diagnostics and laboratory company, announces the acquisition of Dascena Inc.'s Houston-based laboratory business, Dascena Labs, LLC ("Dascena Labs"). Through the acquisition CirrusDx will enhance its current services by further expanding its national laboratory footprint, while strengthening its sequencing capabilities. Dascena Labs is a state-of-the-art CLIA laboratory capable of high-volume …

Sale of Healthmyne to Roche Genentech

…

Sale of Majority Equity Stake in Anodyne to Healthedge Investment Partners

” April 25, 2022 – HealthEdge Investment Partners, LLC (“HealthEdge”), a healthcare focused private equity fund, announced today that it has completed an investment in Anodyne, LLC (“Anodyne”), a leading provider of lifestyle-oriented clinical footwear solutions most commonly prescribed for diabetic patients. Anodyne was founded in 2015 by a group of industry executives who set out to reimagine the diabetic footwear market and establish a new, leading brand—one that would offer patients a variety of modern and stylish shoe selections and suppliers an unmatched service experience. …

Sale of Humanscale Healthcare Business

COLUMBUS, Ohio--(BUSINESS WIRE)--Capsa Healthcare, a leading innovator in healthcare delivery solutions for hospitals, long-term care, and retail pharmacy providers, announced the acquisition of Humanscale Healthcare, a designer and manufacturer of flexible technology solutions and computing workstations based in New York, NY. Capsa’s purchase of Humanscale Healthcare is the company’s seventh major brand acquisition in the last 11 years. With 50+ years of product innovation experience, Capsa has grown steadily through a combination of internal development and acquisition of complementary …

Divestiture of Horizon’s Research Models Business to Envigo

Horizon Discovery Divests Animal Models Business to Envigo * Animal model operations to be transferred to Envigo ownership * Divestment in line with Horizon’s corporate strategy to focus on its core markets * Envigo, a leading global research model supplier, enters the gene-edited research model field with the addition of Horizon’s business * Horizon and Envigo to collaborate on providing CRISPR screening services CAMBRIDGE, England -- November 8, 2019 Horizon Discovery Group plc (LSE: HZD) ("Horizon", “the Company” or “the Group”), a global leader in the application of gene …